3 unknown, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 2, Recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Quratis Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74 QTP101, Placebo - Tuberculosis, Pulmonary | Phase 1 | Recruiting | Quratis Inc. | 144 | 2025-05-09 | 2025-06-17 |
| Study to Assess Safety, Reactogenicity and Immunogenicity of the repRNA(QTP104) Vaccine Against SARS-CoV-2(COVID-19) QTP104 1ug, QTP104 5ug, QTP104 25ug - COVID-19, SARS-CoV-2 | Phase 1 | Unknown | Quratis Inc. | 36 | 2021-11-19 | 2023-05-25 |
| Phase 1 Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Adolescent Placebo, ID93+GLA-SE - Tuberculosis | Phase 1 | Unknown | Quratis Inc. | 36 | 2019-04-02 | 2019-07-23 |
| Phase 2a Clinical Trial of ID93+GLA-SE Vaccine in BCG-vaccinated Healthy Healthcare Workers Placebo, ID93+GLA-SE - Tuberculosis | Phase 2 | Unknown | Quratis Inc. | 107 | 2018-05-31 | 2019-05-31 |
Tuberculosis (2) · COVID-19 (1) · Tuberculosis, Pulmonary (1)
South Korea (4)
Yu Hwa Choi (3) · Jae Chol Choi, MD, PhD (1) · Jinhee Lee, DVM, PhD (1) · Jinsoo Min, MD, PhD (1) · Joon-Sup Yeom, MD/PhD (1) · Kwang Joo Park, MD, PhD (1) · Young Goo Song, MD/PhD (1) · Youngmok Park, MD, PhD (1)